HOYA (OTCMKTS:HOCPY) Upgraded to Buy at Zacks Investment Research

Posted by on Jan 14th, 2021

Zacks Investment Research upgraded shares of HOYA (OTCMKTS:HOCPY) from a hold rating to a buy rating in a research report sent to investors on Wednesday, Zacks.com reports. They currently have $151.00 price target on the technology company’s stock.

According to Zacks, “Hoya Corporation is a specialty manufacturer of optical glass. The Company’s business activities include information technology, eye care, medical, and imaging systems. Its information technologies products include mask blanks and photomasks for semiconductor and LCD, glass memory disks, optical lenses, laser equipment and glass for electronic materials. Its eye care segment includes eyeglass lenses, contact lenses and intraocular lenses while the medical segment includes endoscopic imaging devices and hydroxyapatite. The Company’s imaging system offers digital cameras and CCTV lenses. It also offers system architecture, crystal products, surveying instruments. Hoya Corporation is based in Tokyo, Japan. “

A number of other equities research analysts have also weighed in on the company. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised HOYA from a neutral rating to an outperform rating in a research note on Monday, December 21st. Smith Barney Citigroup upgraded HOYA from a neutral rating to an outperform rating in a report on Monday, December 21st.

OTCMKTS HOCPY opened at $136.72 on Wednesday. HOYA has a 1-year low of $70.36 and a 1-year high of $141.08. The company has a current ratio of 4.95, a quick ratio of 4.16 and a debt-to-equity ratio of 0.02. The stock has a 50-day moving average of $133.04 and a 200-day moving average of $113.45. The firm has a market cap of $51.39 billion, a PE ratio of 50.45 and a beta of 0.45.

About HOYA

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The Life Care segment offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants.

Read More: How is diluted EPS different from basic EPS?

Get a free copy of the Zacks research report on HOYA (HOCPY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for HOYA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOYA and related companies with MarketBeat.com's FREE daily email newsletter.